Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
Search
Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
More
Search
Home
Tags
Exon Skipping
Exon Skipping
Press Releases
Entrada Therapeutics Receives UK Authorization to Begin ELEVATE-44-201
Editorials
Ask the DMD Associations in Your Country: When Will Duchenne Treatments Come to Our Country?
Research
5 DMD Researches You Should Follow up in 2025
Approved Treatments
FDA-Approved Treatments for DMD (Duchenne Muscular Dystrophy)
Research
Next Generation Exon Skipping Therapies Developed for the Treatment of Duchenne Muscular Dystrophy
Research
Dr. Liubov Gushchina’s Exon 17 Skipping Study Rewarded with Grant
Research
Nippon Shinyaku Releases First Clinical Trial (First in Human) of Brogidirsen NS-089/NCNP-02 for the Treatment of Duchenne
Press Releases
Avidity Biosciences Prepares for Three Rare Muscle Disease Programs’ 2025 BLA Submission and Commercialization
Editorials
Turkish DMD Patients Who are Eligible for Exon 51 Skipping Treatment (Eteplirsen) Request Their Medications from the Ministry of Health
1
2
3
Page 2 of 3
Popular
Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy
DMD Warrior
-
December 26, 2024
Must Read
Press Releases
ITF Therapeutics LLC Presents Long-Term Data of DUVYZAT™ (givinostat) for Treatment of Duchenne Muscular Dystrophy at MDA Clinical and Scientific Conference
Press Releases
Avidity Biosciences Announces Positive Topline Del-zota Data Showing Consistent, Statistically Significant Improvements in Dystrophin
Press Releases
Roche to Share Ongoing Work on Elevidys Gene Therapy at Muscular Dystrophy Association (MDA) 2025 Conference